Pimarane diterpenoids for use in wound healing and angiogenesis
Methods and compositions are described for use in encouraging angiogenesis and skin healing as may be utilized in wound treatment, as well as in encouragement of angiogenesis in disease. Compositions include an effective amount of a natural pimarane diterpenoid extract of Hymenocrater elegans , or a derivative, analogue, or homolog thereof. Compounds based upon this natural extract have been found to be highly effective in vascular formation and skin closure while exhibiting low toxicity.
1. A method of increasing angiogenesis in the treatment of a wound in a subject in need thereof, the method comprising administering a pharmaceutical composition comprising a pharmaceutically effective amount of a compound of structure (I) to the wound:
or a tautomer thereof in which R1 and R2 are independently selected from —H, C1-10 alkyl, C1-10 alkoxy, C1-10 alkenyl, C1-10 alkenoxy, —OH, —OAc, —CHO, -Ph, —OC6H5, —OC6H4OH, —COC6H5, —OCONH2, —OCONHCH3, —OCOC6H4NH2, —NH2, or ═O.
2. The method of claim 1 , the compound having the structure:
3. The method of claim 1 , the wound comprising pre-existing vasculature.
4. The method of claim 1 , the pharmaceutical composition further comprising a biocompatible carrier.
5. The method of claim 1 , the method further comprising treating the wound through application of a pharmaceutical appliance comprising the pharmaceutical composition of claim 1 .
6. The method of claim 5 , the pharmaceutical appliance comprising a suture, a staple, gauze, a bandage, a solid wound dressing, or an artificial skin.
7. The method of claim 1 , the pharmaceutical composition further comprising a gel, a cream, or an ointment, the method comprising applying the pharmaceutical composition in a layer on the wound.
8. The method of claim 7 , wherein the wound comprises a skin wound.
9. The method of claim 1 , the pharmaceutical composition comprising the compound of structure (I) in an amount of about 50 wt. % or less by weight of the pharmaceutical composition.
10. The method of claim 1 , the pharmaceutical composition comprising the compound of structure (I) in an amount of from about 10 to about 100 micrograms per milliliter of the pharmaceutical composition.
11. The method of claim 1 , the pharmaceutical composition comprising one or more of the following:
a filler, a diluent, a cleaning agent, a buffer, a preservative, a pH modifier, a toxicity modifier, a mechanical protectant, a chemical protectant, an adsorbent, an antioxidant, a viscosity modifier, an extender, an excipient, an astringent, an emollient, a demulcent, a humectant, an emulsifier, a transdermal delivery enhancing agent, a controlled-release agent, a dye or colorant, a stabilizer, or a lubricant.